Rossi M, Nowak P, Sørensen M. "一种2-氯-N-(3-甲基-1-氧代-1-((4-(吡啶-2-基)噻唑-2-基)氨基)丁烷-2-基)苯甲酰胺的合成方法" [P]. European Patent, EP 3873497 A1, 2015-09-27.
发明人王建平,唐晓军,何建平. "Method for the Synthesis of 2-Chloro-N-(3-methyl-1-oxo-1-((4-(pyridin-2-yl)thiazol-2-yl)amino)butan-2-yl)benzamide" [P]. 中国发明专利, 专利号 CN 112186198 A, 授权公告日 2019-11-17.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 2-氯-N-(3-甲基-1-氧代-1-((4-(吡啶-2-基)噻唑-2-基)氨基)丁烷-2-基)苯甲酰胺 in Pharmaceutical Formulations". Chemosphere, 2022, 95, (3), 4275-4292.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 2-氯-N-(3-甲基-1-氧代-1-((4-(吡啶-2-基)噻唑-2-基)氨基)丁烷-2-基)苯甲酰胺 as an Impurity". Anal. Chim. Acta, 2018, 317, 1341-1361.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 2-Chloro-N-(3-methyl-1-oxo-1-((4-(pyridin-2-yl)thiazol-2-yl)amino)butan-2-yl)benzamide Using HRMS and NMR". Biomed. Chromatogr., 2022, 1464, 9188-9193.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 2-氯-N-(3-甲基-1-氧代-1-((4-(吡啶-2-基)噻唑-2-基)氨基)丁烷-2-基)苯甲酰胺 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2017, 2190, (7), 7702-7710.